Table 4.
Patient characteristics for survivals and nonsurvivals
| Characteristics | Survivors (n = 20) | Nonsurvivors (n = 21) | p |
| Age | 51 ± 15 | 59 ± 18 | 0.1621 |
| Sex | |||
| Male | 14 (70%) | 15 (71%) | 0.92 |
| Female | 6 (30%) | 6 (29%) | |
| APACHE II score | 20.6 ± 3.7 | 23.0 ± 5.7 | 0.12 |
| ALI score | 3.0 ± 0.4 | 3.2 ± 0.3 | 0.1 |
| PaO2/FiO2, mmHg | 126.2 ± 44.2 | 107.0 ± 41.2 | 0.1571 |
| Immune status | |||
| Compromised | 12 (60%) | 5 (24%) | 0.0187 |
| Competent | 8 (40%) | 16 (76%) | |
| Complication rate | 2 (10%) | 6 (29%) | 0.1336 |
| Diagnosis | |||
| Specific | 6 (30%) | 12 (57%) | 0.08 |
| Nonspecific | 14 (70%) | 9 (43%) | |
| Treatment alteration rate | 16 (80%) | 14 (68%) | 0.3355 |
APACHE, Acute Physiology and Chronic Health Evaluation; ALI, acute lung injury; PaO2, arterial partial pressure of oxygen; FiO2, fraction of inspired oxygen. Data are presented as mean ± SD or n (%); p values in italics are statistically significant.